Detalles de la búsqueda
1.
Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study.
BMC Psychiatry
; 22(1): 484, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854248
2.
Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation.
BMC Neurosci
; 19(1): 77, 2018 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30497382
3.
Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.
J Affect Disord
; 308: 236-242, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398108
4.
Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
Neurosci Lett
; 729: 134932, 2020 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224226
5.
Effects of antidyskinetic nicotine treatment on dopamine release in dorsal and ventral striatum.
Neurosci Lett
; 672: 40-45, 2018 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474871
6.
Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Neuropharmacology
; 138: 371-380, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29940207
7.
Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.
Neuropharmacology
; 128: 221-230, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29031851
Resultados
1 -
7
de 7
1
Próxima >
>>